TRPBLUE
TRPBlue specializes in topical therapeutics for the effective prevention and treatment of chemotherapy-induced peripheral neuropathy. The company was founded in 2017 and is headquartered in Durham, North Carolina.
TRPBLUE
Industry:
Health Care Pharmaceutical Therapeutics
Founded:
2017-01-01
Address:
Durham, North Carolina, United States
Country:
United States
Website Url:
http://www.trpblue.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected].
Technology used in webpage:
Person Schema Gravatar Profiles Fastly Hosted
Similar Organizations
Alnara Pharmaceuticals
Alnara Pharmaceuticals develops and commercializes orally-delivered protein therapeutics for the treatment of metabolic diseases.
Burke Therapeutics
Burke Therapeutics specializes in providing prescription products for conditions patients live with each and every day.
Helocyte
Helocyte is a clinical-stage biopharmaceutical company developing novel immunotherapies for the prevention and treatment of cancer.
Microbion
Microbion is a pharmaceutical company developing therapeutics for the treatment of bacterial infections.
MirImmune
MirImmune is a biopharmaceutical company focused on the development of new and improved immunotherapies for cancer.
NRx Pharmaceuticals
NRx Pharmaceuticals is a pharmaceutical company developing therapeutics for the treatment of central nervous system disorders.
Osmol Therapeutics
Osmol Therapeutics develops treatment to prevent chemotherapy-induced peripheral neuropathy.
Penrose TherapeuTx
Penrose TherapeuTx specializes in technological advancements for treating advanced cancers using small-molecule therapies.
Rockland Technimed
Rockland Technimed is a theranostic company that specializes in the early diagnosis and treatment of hypoxia and ischemia injury.
Venturis Therapeutics
Venturis Therapeutics specializes in pre-clinical therapeutic programs for diabetic wounds and cardiovascular diseases using protein drugs.
Current Employees Featured
Founder
More informations about "TRPBlue"
TRPBlue 2025 Company Profile: Valuation, Funding & Investors
TRPBlue General Information Description. Developer of topical therapeutics designed for effective prevention and treatment of effects due to chemotherapy-induced peripheral neuropathy. The โฆSee details»
TRPBLUE, INC. Company Profile | Chapel Hill, NC | Competitors ...
Added by TRPBLUE, INC. This information is updated and provided by TRPBLUE, INC. The content available on the D&B Business Directory is provided "as-is" and "as-available" and โฆSee details»
TRPblue, Inc. :: North Carolina (US) :: OpenCorporates
Free and open company data on North Carolina (US) company TRPblue, Inc. (company number 1646442), 701 Corporate Center Drive, Ste 250, Raleigh, NC, 27607See details»
TRPBlue - Contacts, Employees, Board Members, Advisors & Alumni
Organization. TRPBlue . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. TRPBlue has 1 current โฆSee details»
trpblue.com
We would like to show you a description here but the site wonโt allow us.See details»
TRPblue - VentureRadar
Website: https://trpblue.com. Develops novel small molecule topical therapeutics targeting peripheral nerve pain, itch, and inflammation, based on Duke University research, focusing on โฆSee details»
TRPBlue - Drug pipelines, Patents, Clinical trials - Synapse
100 Translational Medicine associated with TRPBlue. Login to view more data. Corporation Tree. Boost your research with our corporation tree data. login. or. view full example data. Pipeline. โฆSee details»
TRPBLUE, INC. in Chapel Hill, NC | Company Info & Reviews
Mar 9, 2025 TRPBLUE, INC. is a North Carolina Domestic Business Corporation filed on December 19, 2017. The company's filing status is listed as Dissolved and its File Number is โฆSee details»
TRPblue - 136 Donegal Dr, Chapel Hill, NC 27517 - BusinessYab
Trpblue, Inc. has 2 total employees across all of its locations and generates $98,260 in sales (USD). (Sales figure is modelled). TRPblue in Chapel Hill, NC 27517 - (919) 260-5595. โฆSee details»
Duke Physician-scientist Develops Compounds into Gel โฆ
In 2017, Liedtke and partner George โBarneyโ Koszalka, PhD, founded a company called TRPblue with the mission of developing these compounds into a topical treatment, or skin cream, to prevent CIPN. The small business spin off โฆSee details»
TRPBlue - Crunchbase
TRPBlue specializes in topical therapeutics for the effective prevention and treatment of chemotherapy-induced peripheral neuropathy. Search Crunchbase. Start Free Trial . Chrome โฆSee details»
TRPblue โ Duke OTC
A Therapeutics Company Developing A Unique, Dual Acting Inhibitor That Targets Transient Receptor Potential (TRP) Cation Channels TRPV4 And TRPA1. TRPblue has developed small โฆSee details»
Barney Koszalka - Co-Founder @ TRPBlue - Crunchbase
Barney Koszalka is the Co-Founder at TRPBlue. He was a former President and CEO at NeurOp. Jobs. Edit Jobs Section. ... Additionally, Barney Koszalka has had 1 past job as the President โฆSee details»
TRPBlue - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. TRPBlue . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 4. About. TRPBlue is actively using 4 โฆSee details»
Similar companies to TRPblue - VentureRadar
TRPblue profile. Similar Companies to TRPblue. Export Dansk Biotek. n/a. Founded 2010. Unknown. DANISH BIOTECH is a trade organization for Danish biotech companies with the โฆSee details»
Firm | SBIR
Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock A locked padlock) or https:// means โฆSee details»
TroubleNation - Red Wine and Blue
The 2024 election didnโt go our way. So now more than ever, grassroots organizing is going to be critical for doing the work our communities will need: community building, resistance, advocacy โฆSee details»
Troublemaker Resource Page - Red Wine and Blue
Looking for resources and training videos on how to talk about tough issues or organize in your community? You can find it all here.See details»
TRPblue โ 2018 OTC Annual Report
Sep 4, 2018 TRPblue has developed small molecule antagonists that preferentially attenuate signaling of these calcium-permeable channels with proven efficacy in several acute pain and โฆSee details»
Good Trouble turns to youth to improve student motivation in โฆ
2 days ago Last week, the organization held their first State of the Youth event. Joining Minnesota Now to share more about the event and organization is Jose Perez, one of the co โฆSee details»